Ohene Y, Morrey W, Powell E, Smethers K, Luka N, South K
Npj Imaging. 2025; 3(1):8.
PMID: 40051735
PMC: 11879872.
DOI: 10.1038/s44303-025-00071-5.
Lin J, Morisaki M, Sampathkumar S, Lau L, Boche D, Khandaker G
Neurosci Appl. 2024; 3:None.
PMID: 39526037
PMC: 11543635.
DOI: 10.1016/j.nsa.2024.104051.
Doke R, Lamkhade G, Vinchurkar K, Singh S
ACS Pharmacol Transl Sci. 2024; 7(10):2987-3003.
PMID: 39416969
PMC: 11475310.
DOI: 10.1021/acsptsci.4c00457.
Madsen L, Ismail R, Parbo P, Kjeldsen P, Schaldemose J, Hansen K
Alzheimers Dement. 2024; 20(11):8028-8037.
PMID: 39392185
PMC: 11567839.
DOI: 10.1002/alz.14298.
Jin S, Wang J, He Y
Biophys Rep. 2024; 10(4):213-229.
PMID: 39281195
PMC: 11399886.
DOI: 10.52601/bpr.2024.230025.
Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer's disease.
Zatcepin A, Gnorich J, Rauchmann B, Bartos L, Wagner S, Franzmeier N
Mol Neurodegener. 2024; 19(1):64.
PMID: 39238030
PMC: 11375924.
DOI: 10.1186/s13024-024-00752-6.
A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues.
Foss C, Naik R, Das D, Cha H, Minn I, Hall A
EJNMMI Res. 2024; 14(1):76.
PMID: 39186197
PMC: 11347546.
DOI: 10.1186/s13550-024-01133-2.
The development status of PET radiotracers for evaluating neuroinflammation.
Lee N, Choi J, Ryu Y
Nucl Med Mol Imaging. 2024; 58(4):160-176.
PMID: 38932754
PMC: 11196502.
DOI: 10.1007/s13139-023-00831-4.
The longitudinal trajectory of CSF sTREM2: the alzheimer's disease neuroimaging initiative.
Wang Y, Ye M, Ji Q, Liu Q, Xu X, Zhan Y
Alzheimers Res Ther. 2024; 16(1):138.
PMID: 38926894
PMC: 11202383.
DOI: 10.1186/s13195-024-01506-8.
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.
Wissfeld J, Abou Assale T, Cuevas-Rios G, Liao H, Neumann H
Front Neurol. 2024; 15:1330874.
PMID: 38529039
PMC: 10961342.
DOI: 10.3389/fneur.2024.1330874.
PET Imaging to Measure Neuroinflammation In Vivo.
Malpetti M, Franzmeier N, Brendel M
Methods Mol Biol. 2024; 2785:177-193.
PMID: 38427195
DOI: 10.1007/978-1-0716-3774-6_12.
Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis.
Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H
Front Pharmacol. 2024; 14:1287750.
PMID: 38259291
PMC: 10800531.
DOI: 10.3389/fphar.2023.1287750.
Biomarkers in Alzheimer's Disease: Are Olfactory Neuronal Precursors Useful for Biomarker Research?.
Santillan-Morales V, Rodriguez-Espinosa N, Munoz-Estrada J, Alarcon-Elizalde S, Acebes A, Benitez-King G
Brain Sci. 2024; 14(1).
PMID: 38248261
PMC: 10813897.
DOI: 10.3390/brainsci14010046.
Textural properties of microglial activation in Alzheimer's disease as measured by (R)-[C]PK11195 PET.
Pais M, Jorge L, Martins R, Canario N, Xavier A, Bernardes R
Brain Commun. 2023; 5(3):fcad148.
PMID: 37229217
PMC: 10205176.
DOI: 10.1093/braincomms/fcad148.
Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderly.
Ekblad L, Tuisku J, Koivumaki M, Helin S, Rinne J, Snellman A
J Cereb Blood Flow Metab. 2023; 43(9):1588-1600.
PMID: 37113066
PMC: 10414007.
DOI: 10.1177/0271678X231172519.
APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
Snellman A, Ekblad L, Tuisku J, Koivumaki M, Ashton N, Lantero-Rodriguez J
Alzheimers Res Ther. 2023; 15(1):71.
PMID: 37016464
PMC: 10071691.
DOI: 10.1186/s13195-023-01209-6.
Molecular Imaging of Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment.
Kim J, Kim Y
Adv Exp Med Biol. 2023; 1411:301-326.
PMID: 36949316
DOI: 10.1007/978-981-19-7376-5_14.
The 18 kDa translocator protein is associated with microglia in the hippocampus of non-demented elderly subjects.
Tournier B, Snoeijs C, Tsartsalis S, Amosse Q, Farchoukh R, Kovari E
Aging Brain. 2023; 2:100045.
PMID: 36908874
PMC: 9997180.
DOI: 10.1016/j.nbas.2022.100045.
Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging.
Martinez-Coria H, Arrieta-Cruz I, Gutierrez-Juarez R, Lopez-Valdes H
Int J Mol Sci. 2023; 24(5).
PMID: 36901731
PMC: 10001833.
DOI: 10.3390/ijms24054297.
Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia.
Malpetti M, Cope T, Street D, Jones P, Hezemans F, Mak E
Brain. 2023; 146(8):3221-3231.
PMID: 36883644
PMC: 10393407.
DOI: 10.1093/brain/awad078.